Hallux
Phase 2Hallux Inc. is pioneering a new pharmacologic approach with Hallux Subungual Gel (HSG), a terbinafine dosage form applied topically onto the nail bed by a physician.
Founded
2018
Focus
Drug DeliverySmall Molecules
About
Hallux Inc. is pioneering a new pharmacologic approach with Hallux Subungual Gel (HSG), a terbinafine dosage form applied topically onto the nail bed by a physician.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedMay 15, 2023
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile